A Day Up For Mersana Therapeutics, Inc.
Thu, Nov 13, 2025 at 07:17 PM
Mersana Therapeutics, Inc. (MRSN:NASDAQ) soared at $27.43, a gain of 209.2%. On Thu, Nov 13, 2025, MRSN:NASDAQ hit a New 2-Week High of $27.43. The stock appeared on our News Catalysts scanner on Thu, Nov 13, 2025 at 02:22 PM in the 'ACQUISITION' category. From Thu, Oct 30, 2025, the stock recorded 60.00% Up Days and 54.55% Green Days
About Mersana Therapeutics, Inc. (MRSN:NASDAQ)
Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
Top 10 Gainers:
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 368.57%
- Mersana Therapeutics, Inc. (MRSN:NASDAQ), 209.24%
- Nuvve Holding Corp. (NVVE:NASDAQ), 204.61%
- Direct Digital Holdings, Inc. (DRCT:NASDAQ), 44.07%
- Intellicheck, Inc. (IDN:NASDAQ), 37.95%
- TNL Mediagene (TNMG:NASDAQ), 37.18%
- Safe & Green Holdings Corp. (SGBX:NASDAQ), 32.22%
- Cycurion, Inc. (CYCU:NASDAQ), 31.03%
- Apollomics, Inc. (APLM:NASDAQ), 27.87%
- Magnitude International Ltd (MAGH:NASDAQ), 27.84%